Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

1.09
+0.03002.83%
Post-market: 1.090.00000.00%19:58 EDT
Volume:1.08M
Turnover:1.19M
Market Cap:49.88M
PE:-0.97
High:1.15
Open:1.04
Low:1.04
Close:1.06
Loading ...

ImmunoPrecise Antibodies Announces Breakthrough in Universal Dengue Vaccine Development with AI-Driven Safety and Efficacy Validation

Reuters
·
24 Jun

ImmunoPrecise Antibodies Ltd. Unveils Presentation Highlighting Advances in AI-Driven Drug Discovery and Biotherapeutics

Reuters
·
18 Jun

H.C. Wainwright Remains a Buy on ImmunoPrecise Antibodies (IPA)

TIPRANKS
·
13 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Cardinal Health, Adobe

Reuters
·
13 Jun

BUZZ-ImmunoPrecise jumps after AI peptides beat semaglutide in lab tests

Reuters
·
12 Jun

ImmunoPrecise Antibodies Announces Groundbreaking AI-Designed GLP-1 Peptides Surpassing Semaglutide in Receptor Activation Studies

Reuters
·
12 Jun

Immunoprecise Antibodies Ltd - AI-Designed Glp-1 Peptides Surpass Semaglutide in Receptor Activation

THOMSON REUTERS
·
12 Jun

Immunoprecise Antibodies Ltd - Five AI-Optimized Peptide Sequences Tested Against Glp-1 Analogs

THOMSON REUTERS
·
12 Jun

ImmunoPrecise Antibodies Ltd. Unveils AI-Driven Universal Dengue Vaccine Discovery, Paving Way for Broader Infectious Disease Solutions

Reuters
·
05 Jun

Immunoprecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery

THOMSON REUTERS
·
05 Jun

ImmunoPrecise Antibodies Ltd. Unveils Presentation on In Silico Strategies to Harness Rabbit-Derived Antibodies

Reuters
·
28 May

ImmunoPrecise Antibodies Partners with CORE IR to Boost Investor Engagement

Reuters
·
21 May

ImmunoPrecise Antibodies Ltd. to Present at Maxim Group's 2025 Virtual Tech Conference

Reuters
·
20 May

10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure

GlobeNewswire
·
30 Apr

Institutional Property Advisors Brokers Two Class A Office Tower Sale in Newport Beach, California

Business Wire
·
16 Apr

ImmunoPrecise Antibodies Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Apr

ImmunoPrecise Antibodies Price Target Maintained With a $3.00/Share by Benchmark

Dow Jones
·
01 Apr

ImmunoPrecise Antibodies Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
31 Mar

ImmunoPrecise Antibodies price target lowered to $5 from $7 at H.C. Wainwright

TIPRANKS
·
31 Mar

ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024)

Simply Wall St.
·
29 Mar